Further exploration of WDR26 and the CTLH E3 ubiquitin ligase are important to determine if this complex is involved in tau clearance in AD, and if this role is limited to AD or also occurs in other tauopathies. The gene discussed is MAPT; the disease is Alzheimer disease.